HD Ultrasound System enhances intravascular imaging.
Press Release Summary:
Offering detailed insight physicians can use to optimize treatment choice for patients, HDi™ High-Definition Intravascular Ultrasound System (HD-IVUS) includes touchscreen, deliverable Kodama® HD-IVUS catheter, and ACIST HDi console. Touchscreen display features 60 MHz image quality, facilitating identification and interpretation of intravascular structures and disease. Kodama HD-IVUS catheter lowers risk of catheter-induced ischemia by reducing pullback time to seconds.
Original Press Release:
ACIST Launches HDi High-Definition IVUS
High-Definition Resolution, Faster Pullback and Innovative Touch Screen Display Advances IVUS for Cardiologists
EDEN PRAIRIE, Minn. -- ACIST Medical Systems, Inc., a Bracco Group company, pioneer and global market leader of advanced imaging modalities for cardiology, showcased the first-ever HDi((TM)) High-Definition Intravascular Ultrasound System in two live cases at the Transcatheter Cardiovascular Therapeutics meeting in Washington, D.C. The cases were presented from Medstar Washington Hospital Center (Washington, D.C.) and New York-Presbyterian Hospital/Columbia University Medical Center (New York, NY). The HDi features an intuitive touch screen with 60MHz image quality, high-speed pullback, a deliverable Kodama(®) HD-IVUS catheter and the ACIST HDi console. HD-IVUS is a reinvention of intravascular imaging.
The ACIST Medical Systems portfolio has recently expanded beyond the CVi contrast delivery system, to include Rapid Exchange FFR (RXi) and High-Definition IVUS (HDi) technologies. Through these products, ACIST is demonstrating its commitment to bringing unique and innovative technologies that simplify cardiovascular procedures and empower clinicians to treat patients with superior care.
"Improving patient outcomes by offering cardiologists innovative and improved tools is critical to our business," said Tom Morizio, President and COO, ACIST Medical Systems. "Our new HD-IVUS is a highly anticipated technology that offers improvements in an area that has lacked innovation for many years. Physicians tell us they appreciate that ACIST is raising the bar for IVUS performance."
The ACIST HDi IVUS system is easier to use and offers detailed insight that physicians can use to optimize treatment choice for their patients. The HDi provides improved image quality over traditional IVUS systems. During one of the live broadcasts from Columbia Medical Center, world-renowned imaging expert Dr. Akiko Maehara noted, "The ability to visualize plaque morphologies and intravascular structures in high definition is a welcome advancement in imaging."
Additionally, the simple, intuitive touch-screen display features 60MHz image quality, which enables easier identification and interpretation of intravascular structures and disease. The Kodama HD-IVUS catheter is deliverable and offers high-speed pullback that is 20 times faster than currently available IVUS systems--lowering the risk of catheter-induced ischemia by reducing pullback time from minutes to seconds.
"We believe it's our job to provide ongoing innovations for coronary cath labs that improve accuracy, speed, efficiency and delivery," said Dr. Robert Wilson, founder of ACIST Medical Systems. "To continually and dramatically improve technology that improves interventional cardiovascular medicine is our greatest commitment."
About ACIST
ACIST, a Bracco Group company, is a pioneer and global market leader of advanced contrast delivery systems for cardiology. By developing advanced diagnostic technologies that help simplify the complexities of the cardiac cath lab, it empowers clinicians and their teams in providing superior patient care. ACIST products are being used by cardiologists in more than 70 countries worldwide, and more than 15 million patients have benefited from a cardiovascular angiography procedure using an ACIST Contrast Delivery System.
ACIST is headquartered in Eden Prairie, Minn., with regional offices in Europe and Asia. A team of more than 300 people worldwide helps manage and support a portfolio of products and services that simplify and enhance contrast injection procedures. ACIST and its sister company, HLT -- a medical device company dedicated to the development of transcatheter aortic valve technology -- are part of the Bracco Group, an international leader in diagnostic imaging. Both companies share the same founder, president and COO and commitment to innovation in interventional cardiology. Together, they are setting new standards in the industry with the pursuit of emerging cardiology solutions, addressing clinical and physician needs to provide superior patient care. To learn more about ACIST, visit www.acist.com.
About the Bracco Group
Bracco has headquarters in Milan, Italy, and was founded in 1927. It is active in the healthcare sector through Bracco Imaging (diagnostic imaging), Pharma (prescription and over the counter drugs), ACIST Medical Systems and HLT (cardiology) and the Centro Diagnostico Italiano diagnostic clinic. It has around 3,300 employees and annual total consolidated revenues of over 1.2 billion Euro. Bracco operates in more than 90 countries worldwide. To learn more about Bracco Group, visit www.bracco.com.
CONTACT:
Gina Jung
ACIST Medical Systems
Direct: 952 995 9306
info@acistmedical.com
